PLSE

Pulse Biosciences

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 1

Sell signal 0

stock price surged significantly

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About PLSE

Pulse Biosciences, Inc.

A novel bioelectric medicine company that develops medical devices based on a nano-pulse electro signaing platform for the treatment of tumors

Industry

Healthcare Equipment and Supplies

Established Date

05/19/2014

Listing Date

05/18/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.pulsebiosciences.com

Security Type

Common stock

Office address

3957 Point Eden Way, Hayward, CA 94545

Business

Introduction

Pulse Biosciences, Inc., incorporated in Nevada on May 19, 2014 under the name Electroblate, Inc., is a medical device company using a new and proprietary platform technology, nano-pulsed electrical signaling, or NPES in the developmental stage of biomedical applications. Electroblate, Inc., was renamed Pulse Biosciences Corporation, effective December 8, 2015.

Company Financials

EPS

PLSE has released its 2024 Q4 earnings. EPS was reported at -0.17, versus the expected -0.24, beating expectations. The chart below visualizes how PLSE has performed over recent quarters, highlighting trends in earnings surprises.